Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alvotech (ALVO)
NASDAQ:ALVO
Holding ALVO?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.01Last Year’s EPS
-$0.8Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2024
|% Change Since: -0.17%
|Next Earnings Date:Feb 26, 2025
Earnings Call Sentiment|Positive
Alvotech reported significant revenue and margin growth, driven by strong product sales and pipeline advancements. While there were minor FDA inspection observations, these are considered easily manageable. The company faces some uncertainty in revenue timing but remains on track for substantial growth.Company Guidance
During Alvotech's Q3 2024 earnings call, guidance was highlighted with several key metrics demonstrating the company's robust performance and future expectations. Total revenues for the first nine months of 2024 reached $339 million, representing an almost ninefold increase compared to the same period in 2023, with product revenues climbing to $128 million. The company also reported milestone revenues exceeding $210 million year-to-date. The product gross margin showed significant improvement, more than doubling in the third quarter compared to the second quarter, reaching 37%. The company remains optimistic about continued margin expansion due to enhanced utilization of its manufacturing site and shifts in product mix, including the upcoming introduction of the Stelara biosimilar in the U.S. in 2025. Alvotech also reiterated its 2024 revenue guidance of $400 million to $500 million, emphasizing strong product and milestone revenue growth, with expectations of ramped-up shipments in the fourth quarter. Moreover, the company plans to leverage its extensive pipeline, including biosimilar candidates to Eylea and Simponi, to drive future growth, projecting up to one-third of product revenues from markets outside the U.S. by year-end.Significant Revenue Growth
Total revenues for the first 9 months of 2024 increased nearly 9x compared to the same period in 2023, reaching $339 million.
Record Product Revenues
Product revenues for the first 9 months were $128 million, a 330% increase from the prior year, with the highest recorded quarter at $62 million.
Increased Product Margins
Product margins improved significantly, reaching 37% in Q3 2024 compared to 17% in Q2.
Strong Pipeline and Approvals
EMA acceptance for AVT03 and AVT05, and U.S. approval for an additional presentation of SELARSDI, a biosimilar to Stelara. AVT16 is now in patient trials.
Strategic Partnerships and Global Expansion
Ex-U.S. launches of AVT02 and AVT04 in multiple markets, with strong demand in the European Union. 1/3 of product revenues expected from outside the U.S. in 2024.
---
ALVO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ALVO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $11.93 | $12.07 | +1.17% |
| Aug 15, 2024 | $11.93 | $12.97 | +8.72% |
| May 21, 2024 | $13.94 | $14.00 | +0.43% |
| Mar 20, 2024 | $15.23 | $15.07 | -1.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Alvotech (ALVO) report earnings?
Alvotech (ALVO) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Alvotech (ALVO) earnings time?
Alvotech (ALVO) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ALVO EPS forecast?
ALVO EPS forecast for the fiscal quarter 2024 (Q4) is $0.01.
---